Articles

Despite decades of research, cancer remains one of the most complex challenges in modern medicine.The difficulty stems from its dynamic nature: it is not a single disease, but an evolutionary process fueled by profound transformations in cell behavior. Understanding these steps is essential to grasp why therapies targeting a single mechanism are often insufficient and why the most promising strategies today aim to hit multiple biological pathways simultaneously. The first fun

For a long time, cancer has been considered a disease primarily linked to aging. Today, however, epidemiological data tell a more complex story. By the end of 2025, a surprising picture emerges: while overall cancer mortality decreases thanks to targeted therapies, the incidence of tumors among adults under 50—known as early-onset cancers—is rising. An analysis reported by the New York Times and supported by studies published in Annals of Internal Medicineindicates that six t

Professor Antonio Giordano now contributes a dedicated column titled “Medicine – Highlights” to Il Mattino, one of Italy’s most esteemed and widely circulated daily newspapers, long-established as a cornerstone of Southern Italian journalism. This column will appear every Sunday in both print and digital formats. It serves as an insightful space for in-depth research with Professor Giordano, extending beyond the frontiers of medicine to the profound significance of human well

Antonio Giordano: Scientific curiosity brought me to the USA to fight cancer